Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07638150 · ClinicalTrials.gov registry record · NA
PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME)
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07638150 is a NA study that has not yet begun recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT07638150, a NA study, has not yet begun recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This single-arm pilot study evaluates the feasibility and acceptability of a 4-week Mediterranean diet-based feeding intervention as nutritional prehabilitation for newly diagnosed, treatment-naïve breast cancer patients prior to surgery. All meals are provided to participants. Secondary aims include assessing changes in body composition, metabolic biomarkers, inflammation, gut microbiome composition, patient-reported outcomes, and clinician-reported surgical recovery metrics.
Interventions
- OTHER Mediterranean Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-08 |
| Est. Completion | 2027-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07638150
The ClinicalTrials.gov registry entry for NCT07638150 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mediterranean Diet is the first listed.
NCT07638150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07638150 about?
NCT07638150 is a clinical study titled "PRehabilitation Intervention to Modify Eating for Breast Cancer Patients (PRIME)". This single-arm pilot study evaluates the feasibility and acceptability of a 4-week Mediterranean diet-based feeding intervention as nutritional prehabilitation for newly diagnosed, treatment-naïve breast cancer patients prior to surgery. All meals are provided to participants. Secondary aims includ...
What is the current status of trial NCT07638150?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-08. Estimated completion is 2027-04.
What interventions are being tested in trial NCT07638150?
The interventions under investigation include: Mediterranean Diet (OTHER).
Who is sponsoring clinical trial NCT07638150?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.